Skip to main content
. 2022 Aug 15;21:15330338221119745. doi: 10.1177/15330338221119745

Figure 1.

Figure 1.

Expression and clinical significance of USP14 in tumors with p53 deficiency. a-c, The expression level of p53 (a) and USP14 (b) and their correlation (c) in 12 DLBC tissues and 5 noncancerous tissues from GEO dataset GSE26725. d, The Kaplan-Meier method was used to evaluate the relationship between USP14 expression and overall survival of 42 DLBC patients from TCGA dataset. e-g, The expression level of p53 (e) and USP14 (f) and their correlation (g) in 258 SARC tissues and 3 noncancerous tissues from TCGA dataset. h, The Kaplan-Meier method was used to evaluate the relationship between USP14 expression and overall survival of 258 SARC patients from TCGA dataset. i-l, The expression level of p53 (i) and USP14 (j) and their correlation (k) in 19 OS tissues and 4 noncancerous tissues from GEO dataset GSE28425. l, The Kaplan-Meier method was used to evaluate the relationship between USP14 expression and overall survival of 86 OS patients from TCGA dataset. DLBC, diffuse large b-cell lymphoma; SARC, sarcoma; OS, osteosarcoma.